期刊文献+

原发性膜性肾病患者外周血淋巴细胞亚群的变化及其与蛋白尿的关系 被引量:5

Changes of peripheral blood lymphocyte subgroups in patients with primary membranous nephropathy and their relationship with proteinuria
下载PDF
导出
摘要 目的分析原发性膜性肾病(PMN)患者外周血淋巴细胞亚群的变化及其与蛋白尿的关系。方法选取新乡医学院一附院肾内科确诊的PMN患者40例,收集其详细临床资料,并留取外周血应用流式细胞仪测定淋巴细胞亚群(CD3+、CD4+、CD8+、CD4+/CD8+、CD16+CD56+、CD19+),同时选取20例健康志愿者作为健康对照组,比较PMN患者外周血淋巴细胞亚群与健康对照组的差别。根据患者尿蛋白水平,将PMN患者分为大量蛋白尿组(尿蛋白定量大于或等于3.5g/d)及非大量蛋白尿组(尿蛋白定量小于3.5g/d),分析两组患者上述淋巴细胞亚群水平的差异及其可能的临床意义。结果 (1)和健康对照组相比,PMN患者外周血CD4+细胞计数有升高趋势(51.83±6.80 vs.43.5±5.65,P>0.05),CD8+细胞计数有降低趋势(28.83±5.60 vs.35.33±5.00,P>0.05),而CD4+/CD8+比值较健康对照组明显升高(1.86±0.43 vs.1.27±0.33,P<0.01)。与健康对照组比较,PMN患者外周血CD16+56+细胞计数无明显差异,而CD19+细胞计数明显升高(8.00±2.76 vs.7.33±2.66,P<0.01)。(2)和非大量蛋白尿组相比,大量蛋白尿组CD19+细胞计数明显高升高(9.80±3.19 vs.7.10±2.23,P<0.01),而CD4+细胞、CD8+细胞计数、CD4+/CD8+比值两者间差异均无统计学意义(P>0.05)。结论 PMN患者表现出明显的B淋巴细胞异常和CD4+/CD8+细胞比值的偏移,且B淋巴细胞异常程度与蛋白尿量有关,因此,监测PMN患者淋巴细胞亚群变化有助于评估病情、指导治疗。 Objective To analyze the changes of lymphocyte subgroups in peripheral blood for the patients with primary membranous nephropathy(PMN)and their relationship with proteinuria .Methods 40 cases of PMN in the nephrology department of our hospital were selected and their detailed clinical data were collected .The peripheral blood was collected for detecting the levels of lymphocyte subgroups (CD3^+ ,CD4^+ ,CD8^+ ,CD4^+ /CD8^+ ,CD16^+56^+ ,CD19^+ ) by the flow cytometry .Simultaneous 20 healthy volunteers were selected as the control group .The differences in peripheral blood lymphocyte subgroups were compared between the PMN patients and the healthy con‐trol group .According to the proteinuria levels ,the PMN patients were divided into the massive proteinuria group (MPG ,proteinuria quantity≥3 .5 g/d) and the non‐massive proteinuria group(NMPG ,proteinuria quantity〈3 .5 g/d) .The differences in peripheral blood lymphocyte subgroups were compared between the MPG group and the NMPG group and their possible clinical significance was investigated .Results (1) Compared with the healthy con‐trol group ,the CD4^+ cell levels had a rising trend(51 .83 ± 6 .80 vs .43 .5 ± 5 .65 ,P〉0 .05) and the CD8^+ cell levels had a downward trend(28 .83 ± 5 .60 vs .35 .33 ± 5 .00 ,P〉0 .05) in the PMN patients ,while the CD4^+ /CD8^+ ratio was significantly increased compared with the healthy control group (1 .86 ± 0 .43 vs .1 .27 ± 0 .33 ,P〈0 .01) .There was no significant difference in the CD16^+CD56^+ count between two groups ,while the CD19^+ cell count in the PMN patients was significantly increased(8 .00 ± 2 .76 vs .7 .33 ± 2 .66 ,P〈0 .01) .(2) Compared with the NMPG group , the CD19^+ cell count in the MPG group was significantly increased(9 .80 ± 3 .19 vs .7 .10 ± 2 .23 ,P〈0 .01) ,while the CD4^+ cell count ,CD8^+ cell count and the CD4^+ /CD8^+ ratio had no statistically significant differences between the MPG and NMPG groups .Conclusion PMN patients appear obvious abnormalities of B lymphocytes and the shift of CD4^+ /CD8^+ cells ratio .The abnormal degree of B lymphocyte is related to proteinuria quantity .Therefore ,monito‐ring the lymphocyte subgroups changes can help to assess the disease condition and guide the treatment .
出处 《检验医学与临床》 CAS 2015年第1期55-57,共3页 Laboratory Medicine and Clinic
关键词 原发性膜性肾病 淋巴细胞亚群 蛋白尿 primary membranous nephropathy lymphocyte subgroups proteinuria
  • 相关文献

参考文献12

  • 1Ardalan M. Triggers, bullets and targets,puzzle of mem-branous nephropathy [ J]. Nephrorol Mon, 2012,4(4):599-602.
  • 2Masutani K,Taniguchi M, Nakashima H, et al. Up-regu-lated interleukin-4 production by peripheral T-helper cellsin idiopathic membranous nephropathy [J]. Nephrol DialTransplant,2004?19(3) :580-586.
  • 3Hirayama K? Ebihara I, Yamamoto S, et al. Predominanceof type-2 immune response in idiopathic membranous ne-phropathy. Cytoplasmic cytokine analysis [J]. Nephron,2002,91(2):255-261.
  • 4Hanko JB,Mullan RN,O Rourke DM,et al. The changingpattern of adult primary glomerular disease [J]. NephrolDial Transplant,2009,24( 10) .3050-3054.
  • 5潘俊美,尹忠诚,李胜开.1217例肾活检患者临床与病理资料分析[J].临床内科杂志,2013,30(3):179-181. 被引量:6
  • 6Pereira WF,Brito-Melo GE,Guimaraes FT,et al. The roleof the immune system in idiopathic nephrotic syndrome:areview of clinical and experimental studies [ J], InflammRes,2014,63(1):1-12.
  • 7Van der Zee JS, Aalberse RC. The role of IgG in immedi-ate-type hypersensitivity [J]. Eur Respir J,1991,13 : 91s-96s.
  • 8Kuroki A, Iyoda M, Shibata T,et al. Th2 cytokines in-crease and stimulate B cells to produce IgG4 in idiopathicmembranous nephropathy[J]. Kidney Int,2005,68 (1):302-310.
  • 9王波,刘志红,吴燕,左科,黄倩,秦卫松,曾彩虹,黎磊石.特发性膜性肾病患者调节性T细胞和B淋巴细胞的变化及其临床意义[J].肾脏病与透析肾移植杂志,2009,18(4):322-328. 被引量:17
  • 10Remuzzi G, Chiurchiu C,Abbate M, et al. Rituximab foridio-pathic membranous nephropathy [J]. Lancet,2002,360(9337) :923-924.

二级参考文献21

  • 1汤梦娟,刘映红,卓莉,许向青,彭佑铭.成人608例肾活检临床病理分析[J].中国医师杂志,2006,8(8):1126-1127. 被引量:13
  • 2黎磊石,关天俊,刘志红,俞雨生,唐政,陈惠萍,王庆文,姚小丹.4298例成年人肾小球疾病病理类型及流行病学特点[J].肾脏病与透析肾移植杂志,1997,6(2):103-109. 被引量:160
  • 3Ponticelli C, Passerini P. Membranous glomerulonephritis. In:Massry SG, Glassock R J, et al. Massry & Glassockps Textbook of Nephrology. 4th ed. Philadelphia: Lippineott Williams Wilkins, 2001,707 -713.
  • 4Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13, 519 renal biopsies. Kidney Int, 2004, 66 (3) : 920 - 923.
  • 5Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N EnglJ Med, 2009,361 ( 1 ) : 11 - 21.
  • 6Ruggenenti P, Chiurchiu C, Brusegan V, et al. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soe Nephrol, 2003, 14(7) : 1851 -1857.
  • 7Kuroki A, Iyoda M, Shibata T, et al. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephrop athy. Kindnet Int, 2005, 68 : 302 - 310.
  • 8Cohen CD, Calvaresi N, Armelloni S, et al. CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol, 2005, 18: 328 - 333.
  • 9Fontenot J, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4^+ CD25^+ regulatory T cells. Nat Immunol, 2003, 4(4) : 330 -336.
  • 10Jonuleit H, Schmitt E, Kakirman H, et al. Infectious tolerance: human CD25^ + regulatory T cells convey suppressor activity to conventional CD4^ + T helper cells. J Exp Med, 2002, 196 (2) : 255 - 260.

共引文献21

同被引文献43

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部